Completed
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-03-25
N/A
Participants Needed
N/A
Research Sites
343 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia.
CONDITIONS
Official Title
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
Men aand women with angiographically documented coronary artery disease, ischemia on both stress (exercise) testing and 48-hour ambulatory electrocardiogram monitoring, and who were amenable to revascularization.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here